Indiana has too many nursing homes
Indiana has 58 percent more nursing homes per resident and spends an extra $1 billion per year on care in nursing homes than the average for the rest of the country.
Life Science & Biotech
Articles
Patients, providers respond after Anthem promotes lower-cost MRI facilities
Anthem patients in five U.S. cities, including Indianapolis, spent $220 less per MRI scan after Anthem told them of lower-cost facilities. In response, hospital-owned MRI facilities cut their prices.
Lilly wins tentative approval for diabetes drug
Final approval could be delayed until mid-2016 due to a claim of patent infringement by drugmaker Sanofi.
Indiana’s tax breaks for jobs cost at least three times more than Medicaid expansion
State and local governments hand out $921 million per year to entice business to add jobs. The Medicaid expansion is estimated to cost no more than $279 million per year.
Is this the future of rural health care: Walmart, walk-in clinics and an ambulance?
In two to three years, primary care clinics could be popping up in Walmart stores in rural Indiana while most rural Indiana hospitals will offer little to no inpatient services. That’s dramatically different from what we’re used to.
Biotech comeback: Eli Lilly making renewed push in lucrative field it once pioneered
Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.
Hendricks County pitching motorsports skill, expertise to medical manufacturers
Hendricks County finds pay dirt pitching skills of racing industry to medical device manufacturers.
More patients help drug firms pass ‘valley of death’
In spite of the beaucoup bucks in the pharma sector, patients, along with their families and committed advocates, are turning out to be better sources of funding for early stage companies because they tolerate risk better than drug companies and investors.
The most likely conflict zone between Pence, Obama
Gov. Mike Pence thinks his HIP 2.0 plan would reform Medicaid in line with conservative principles. To the extent the Obama administration agrees, that’s the biggest hurdle to get the plan approved.
Small employers dumping plans faster than expected, WellPoint says
WellPoint saw 218,000 members of its health plans disappear because their employers ended their group plans. Other insurers, however, say small employers are ending their plans more slowly than expected.
Indiana health startups have raised $100M this year
Investors seem to have rediscovered the Midwest this year, pouring a record $777 million into 139 companies, according to BioEnterprise. In the first half of 2013, Midwest companies raised $351 million.
Should IU Health pursue a strategy of mediocrity?
Indiana University Health fell off U.S. News’ honor roll of the nation’s top 1 percent of hospitals. Because of Obamacare and other trends, perhaps IU Health should be happy about that.
Most drug money in Indiana funds research. Is that good?
With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That’s not the same thing as paying to market drugs, but it’s hardly without controversy.
Med school plots researcher hiring spree
The Indiana University School of Medicine plans to hire 100 research professors over the next five years in a bid to vault into the top 25 medical schools.
If courts gut Obamacare, Pence will face tough choice
If this week’s D.C. appeals court ruling stands up—declaring the Obamacare tax subsidies illegal in Indiana and most other states—Gov. Mike Pence could face significant pressure, even from traditional Republican supporters, to keep the tax credits flowing.
Lilly sales, profit drop but beat analysts’ expectations
Indianapolis-based Lilly and Co. lost 17 percent of its revenue during the second quarter as U.S. patents expired on its bestselling drugs Cymbalta and Evista.
Dow Agro reports record second-quarter sales
Dow AgroSciences LLC posted sales of $1.9 billion in the second quarter, an increase of 3 percent over last year's second period, the Indianapolis-based company reported Wednesday morning.
Will hospitals’ higher facility fees survive health reform?
One of the open secrets in health care is that hospitals are paid substantially more than independently owned health care facilities for the same procedures. But those higher fees are facing unprecedented pressure.
Indy hospitals continue to see fewer patients. Why?
All of sudden, Hoosiers are buying less health care. Is that because we’ve kicked the habit, sobered up and found religion? Or is it the Great Recession hangover that will pass, eventually, so we can all get back to the party?